At a glance
ClinicalIndex Comparison RecordN/ACompleted· 682 enrolled
Drug / intervention
Blood sampling +2 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Analysis of Circulating Tumor Markers in the Blood
In Brief
A clinical study evaluating Blood sampling, Tumor sampling, and 1 other intervention for Cancer. Completed, enrolled 682 participants across 5 sites.
Detailed Summary
Exploratory study on blood-borne biological markers and their correlation with clinical and pathological characteristics.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
First PostedAug 2016
Primary CompletionJul 2024
Study CompletionSep 2024
TodayJul 2026
First PostedAug 15, 2016
Enrollment StartJul 1, 2015
Primary CompletionJul 1, 2024
Study CompletionSep 1, 2024
TodayJul 2, 2026
Enrollment to primary: 9 yearsPosted 9.9 years ago
Interventions
Blood samplingbiological
Up to 5 blood samplings can be performed at different time points
Tumor samplingprocedure
One tumor sampling can be performed, if applicable
Stool samplingother
Up to 5 blood samplings can be performed at different time points